Thymosin α 1 potentiates interleukin 2-induced cytotoxic activity in mice
- 1 March 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 133 (1) , 196-205
- https://doi.org/10.1016/0008-8749(91)90191-d
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Therapeutic immunopharmacologyCurrent Opinion in Immunology, 1990
- Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytesInternational Journal of Immunopharmacology, 1990
- Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organsCancer Immunology, Immunotherapy, 1989
- Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing miceInternational Journal of Immunopharmacology, 1989
- Human Natural Lymphocyte Effector Cells: Definition, Analysis of Activity, and Clinical EffectivenessJNCI Journal of the National Cancer Institute, 1988
- In vitro and In vivo antitumor activity of lymphokine‐induced cytotoxic cellsInternational Journal of Cancer, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- IN VIVO ADMINISTRATION OF INTERLEUKIN-2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSESTransplantation, 1983
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983